TuisRXRX • NASDAQ
add
Recursion Pharmaceuticals Inc
Vorige sluiting
$7,26
Dagwisseling
$6,78 - $7,08
Jaarwisseling
$5,60 - $15,74
Markkapitalisasie
2,69 mjd USD
Gemiddelde volume
16,46 m
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NASDAQ
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 26,08 m | 147,62% |
Bedryfskoste | 37,76 m | 29,31% |
Netto inkomste | -95,84 m | -3,04% |
Netto winsgrens | -367,46 | 58,39% |
Wins per aandeel | -0,34 | 20,93% |
EBITDA | -91,16 m | 0,89% |
Effektiewe belastingkoers | -0,17% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 427,65 m | 10,41% |
Totale bates | 726,50 m | 15,17% |
Totale aanspreeklikheid | 201,94 m | 4,71% |
Totale ekwiteit | 524,56 m | — |
Uitstaande aandele | 286,84 m | — |
Prys om te bespreek | 3,97 | — |
Opbrengs op bates | -32,73% | — |
Opbrengs op kapitaal | -38,14% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | -95,84 m | -3,04% |
Kontant van bedrywe | -59,22 m | 18,78% |
Kontant van beleggings | -4,56 m | -1 214,70% |
Kontant van finansiering | 16,46 m | -69,38% |
Netto kontantverandering | -46,92 m | -139,19% |
Beskikbare kontantvloei | -16,60 m | 70,89% |
Meer oor
Recursion Pharmaceuticals is a clinical-stage biotechnology company that focuses on mapping and decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering.
The company is based in Salt Lake City, Utah. It was founded by Chris Gibson, Dean Li and Blake Borgeson. Wikipedia
Gestig
2013
Hoofkwartier
Webwerf
Werknemers
500
